Skip to main content
Benhur Lee, MD, Pathology, New York, NY

BenhurLeeMD

Pathology New York, NY

Blood Banking & Transfusion Medicine, Anatomic Pathology, Clinical Pathology

Professor of Microbiology, Icahn School of Medicine at Mount Sinai

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

  • Office

    ONE GUSTAVE L. LEVY PLACE
    #1124
    New York, NY 10029
    Phone+1 212-241-2552

Summary

  • Professor Benhur Lee is a virologist with wide-ranging research interests who joined the Department of Microbiology at the Icahn School of Medicine at Mount Sinai (ISMMS) in 2014. He holds the Ward-Coleman Chair in Microbiology. Prior to his recruitment to Mount Sinai, Dr. Lee spent 12+ years as a member of the Department of Microbiology, Immunology & Molecular Genetics as well as the Department of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA (University of California, Los Angeles). He joined UCLA in 2001 as an Assistant Professor, and was promoted to Associate Professor in 2007, and to full Professor in 2011. Dr. Lee graduated from Yale University School of Medicine in 1995 with an M.D. and induction into the National Medical Honor Society (Alpha Omega Alpha), and did his clinical and post-doctoral training at the University of Pennsylvania Medical Center (1995-2001) where he also served as Chief Resident (1997). He worked on HIV fusion and entry during his post-doctoral years under Dr. Robert Doms (1997-2001).

    Dr. Lee is board-certified in Clinical Pathology and was an attending physician on the Transfusion Medicine Service at UCLA.

    Dr. Lee has a special interest in emerging paramyxoviruses such as henipaviruses. He has made substantial contributions to our understanding of henipavirus entry and budding mechanisms. His latest interests include engineering paramyxovirus-based vectors for gene therapy applications. Dr. Lee has published over 140 peer-reviewed publications (h index=47), and sits on multiple editorial boards. He is a member of the NIH recombinant DNA Advisory Committee (RAC), and the ICTV Paramyxovirus study group. He has trained more than a dozen post-doctoral fellows, 16 graduate students, and has served on more than 60 PhD dissertation committees between UCLA and Mount Sinai.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1995 - 2000
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemChief Residency, Pathology-Anatomic and Clinical, 1996 - 1997
  • Yale School of Medicine
    Yale School of MedicineClass of 1995
  • Santa Clara University
    Santa Clara UniversityBS, Magna cum laude, 1984 - 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2002 - 2023
  • American Board of Pathology Clinical Pathology

Awards, Honors, & Recognition

  • Recombinant DNA Advisory Committee (RAC) National Institutes of Health (NIH), 2016-2020
  • Paramyxoviridae Study Group International Committee on Taxonomy of Viruses, 2017
  • Scientific Advisor, Standards Working Group California Institute of Regenerative Medicine (SWG, CIRM), 2015-2017
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Development of a Neutralization Assay for Nipah Virus Using Pseudotype Particles.  
    A.Tamin, B. H. Harcourt, M. K. Lo, J. A. Roth, M. C. Wolf, B. Lee, H. Weingartl, J-C. Audonnet, W. J. Bellini and Paul A. Rota, J Virol Methods, 160:1-6
  • Expression and coreceptor function of APJ for primate immunodeficiency viruses.  
    Puffer BA, Sharron M, Coughlan CM, Baribaud F, McManus CM, Lee B, David J, Price K, Horuk R, Tsang M, Doms RW, Virology, 276:435-44
  • DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans.  
    Pohlmann S, Soilleux EJ, Baribaud F, Leslie GJ, Morris LS, Trowsdale J, Lee, B, Coleman N, Doms RW, Proc Natl Acad Sci USA. 98:2670-2675
  • Join now to see all

Books/Book Chapters

Lectures

  • Emerging paramyxoviruses: diversity and danger? 
    Yale University Microbiology Seminar Series - 2/16/2017
  • CRISPR-Cas9 Mediated Efficient and Complete Knock-In of Destabilization Domain-Tags Allows for Reversible and Regulated Knock-Out of Protein Function 
    Protein Expression System Engineering, PEGS, Boston, MA - 4/28/2016
  • Out of Africa: Emerging Paramyxovurses 
    Princeton University, Infectious Disease Dynamics Group Research Seminar, Princeton, NJ - 4/13/2016
  • Join now to see all

Other

Press Mentions

  • Trivalent NDV-HXP-S Vaccine Protects Against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
    Trivalent NDV-HXP-S Vaccine Protects Against Phylogenetically Distant SARS-CoV-2 Variants of Concern in MiceJune 6th, 2022
  • What Is It About the Delta Variant That Makes It Spread so Easily?
    What Is It About the Delta Variant That Makes It Spread so Easily?July 30th, 2021
  • No, There Is No Evidence the COVID-19 Vaccine Spike Protein Is ‘Cytotoxic’
    No, There Is No Evidence the COVID-19 Vaccine Spike Protein Is ‘Cytotoxic’June 24th, 2021
  • Join now to see all